Barbiturates commercial

Barbiturates (Veronal. Barbital, Luminal, Amytal), ethyl orthoformate, and other chemicals are produced commercially from sodium ethoxide. 

Methohexitone (Figure 4.3) is a water-soluble, methylated barbiturate with a pKa of 7.9. It is commercially available as a white powder, combined with 5% anhydrous sodium carbonate. The resultant 1% solution has a pH of 11.1 and although stable, when refrigerated for 6 weeks, should be discarded after 24 hours, as it does not contain an antibacterial preservative. 

By 1912, von Mering and Fischer developed and commercially introduced a new barbiturate compound for sleep and anxiety called phenobarbital or Luminal. However, this medication quickly found its place as treatment for a very different medical condition, epilepsy, which is a condition of periodic, unprovoked convulsions or seizures. The main goal of epilepsy treatment is to decrease the frequency of seizures. Alfred Hauptmann discovered the anti-epileptic properties of phenobarbital accidentally. A 1912 report by Hauptmann described epileptic patients who were given phenobarbital for sedation and incidentally had fewer seizures. Seizures are caused by an abnormal impulse in the brain, which spreads and sends inappropriate message to the body. These messages result in... 

Subsequently, Purdie and coworkers studied the CD induced in phencyclidine (and its pyrrolidine and morpholine analogues), 6-phenethylamine, phenobarbital, meperidine HC1, diazepam, and dilantin by 6-cyclodextrin [59], In this work, a method was described for the assay of meperidine in commercially available Demerol tablets. The complexation between 6-cyclodextrin and eight 5,5-disubstituted derivatives of barbituric acid was characterized on the basis of the... 

To synthesize the target barbiturate 36 we identified l-bromo-8,8,8-trifluorooctane 43 (see Scheme 4.6) as the key building-block. This molecule is known, and was previously obtained only by fluorination of 8-bromooctanoic acid with SF4 [37]. Unfortunately, the use of such an aggressive fluorinating agent requires specific experimental apparatus and presents considerable safety hazards, which are difficult to address in an ordinary synthetic laboratory. We therefore developed several alternative routes to 43 based on user-friendly protocols as well as the use of a cheap and commercially available source of fluorine, such as trifluoroacetic esters. One of these novel approaches is shown in Scheme 4.6. 

Enzyme inhibition assays conducted on a set of commercially available MMPs (see Table 4.3) showed that 36 is considerably more potent and more selective than the parent unfluorinated barbiturate C. More specifically, 36 is 100-fold more potent than C for MMP-9 inhibition and has an MMP-2/MMP-9 selectivity factor of 60, whereas the selectivity factor for C is only 2. 

Concentrating on one of these classes, we note in Figure 5 that 27 of 34 commercial barbiturates have ethyl or... 

In addition to drugs from illicit sources, the forensic scientist will sometimes be faced with casework involving samples diverted from legitimate, e.g. commercial, sources. Of these, perhaps the most significant are barbiturates (often found in heroin samples) and benzodiazepines. Both are found under a wide variety of trade names, but the approach to their analysis is broadly similar, either when the material is encountered in the native dosage form, or when it is part of a drug mixture. 

In the solid (crystalline) form the barbituric acid exists in the triketo or lactam form. In aqueous solution tautomerism to the enolic lactim occurs the enolic hydroxyl (at C-2) is acidic acid and is ionized according to the particular drug s pKa (e.g., pentobarbital = 8.0, phenobarbital = 7.5). Titrating such a solution with a stoichiometric equivalent of base such as NaOH will convert the lactam quantitatively to the barbiturate s sodium salt, which can be isolated. Many barbiturates are commercially produced both in the lactam and in the sodium enolate salt form. Of course, the salts are water soluble and thus are used to formulate injectable dosage forms including those for IV anesthetic use. 

Which of the commercially available barbiturates is the longest acting ... 

Barbituric acid was found to be useful in the production of rifomycin B from Streptomyces mediterrmei. Ordinarily, a mixture of antibiotics is produced, difficult to separate on a commercial scale, but with barbituric acid present, rifomycin B is the only antibiotic produced [124]. Barbituric acid is an inhibitor of the destruction of penicillin by penicillinase, although not as good as some other compounds [125]. 

Within the last two decades, a number of chemical structures have been proposed as metal deactivators for polyolefins. These include carboxylic acid amides of aromatic mono- and di-carboxylic acids and N-substituted derivatives such as N,N -diphenyloxamide, cyclic amides such as barbituric acid, hydrazones and bishydrazones of aromatic aldehydes such as benzaldehyde and salicylaldehyde or of o-hydroxy-arylketones, hydrazides of aliphatic and aromatic mono- and di-carboxylic acids as well as N-acylated derivatives thereof, bisacylated hydrazine derivatives, polyhydrazides, and phosphorus acid ester of a thiobisphenol. An index of trade names and suppliers of a few commercial metal deactivators is given in Appendix A4. 

An interesting work showing the applicability of SSNMR to polymorphism discrimination and crystal structure analysis has been recently presented by Zencirci et al. [96]. In that work, new studies on Barbital, the first commercially available barbiturate, were performed. Barbital presented several polymorphs and solvates, C SSNMR experiments allowed to determine differences in the crystal structure of the different forms, together with differences in the hydrogen bonds conformations. 

---